The UVA Focused Ultrasound Cancer Immunotherapy Center leverages existing strengths of UVA (a Focused Ultrasound Center of Excellence), which include cancer immunotherapy, focused ultrasound, and medical imaging, as well as the expertise and support of the Focused Ultrasound Foundation. The goal of the center is to improve quality of life, increase longevity, and improve access to and decrease the cost of care for patients with a variety of cancers – including glioblastoma, pancreatic cancer, breast cancer, and melanoma – by augmenting the effectiveness of cancer immunotherapy with focused ultrasound. Led by Co-Directors Richard J. Price, PhD, Craig Slingluff, MD, and David Brenin, MD, the center is the first of its kind in the world.

The center is built on a powerful multidisciplinary and interdepartmental collaboration between medical and surgical oncology, radiology, radiation oncology, and biomedical engineering. A combined initial investment of $8 million from UVA, the Foundation, and the Commonwealth of Virginia is being used to purchase state-of-the-art focused ultrasound devices, hire scientists and staff, and fund laboratory research studies and clinical trials.